相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GPR10 gene deletion in mice increases basal neuronal activity, disturbs insulin sensitivity and alters lipid homeostasis
Veronika Prazlenkova et al.
GENE (2021)
Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation
Patricio Atanes et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study
Alena Karnosova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cholecystokinin System Is Involved in the Anorexigenic Effect of Peripherally Applied Palmitoylated Prolactin-Releasing Peptide in Fasted Mice
Zdenko Pirnik et al.
PHYSIOLOGICAL RESEARCH (2021)
Drug Therapy in Obesity: A Review of Current and Emerging Treatments
David M. Williams et al.
DIABETES THERAPY (2020)
Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats
Martina Cermakova et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years
Frances Rose et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status
Maushmi S. Kumar
FRONTIERS IN NUTRITION (2019)
Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice
Martina Holubova et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice
Zdenko Pirnik et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study
Barbora Mikulaskova et al.
NUTRITION & DIABETES (2018)
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues
Esben M. Bech et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity
Veronika Prazienkova et al.
PLOS ONE (2017)
Cardiovascular consequences of metabolic syndrome
Johnathan D. Tune et al.
TRANSLATIONAL RESEARCH (2017)
Lipopeptides as therapeutics: applications and in vivo quantitative analysis
Jana Zemenova et al.
BIOANALYSIS (2017)
Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk
Sarmad Said et al.
CURRENT VASCULAR PHARMACOLOGY (2016)
Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats
Martina Holubova et al.
JOURNAL OF ENDOCRINOLOGY (2016)
Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination
Helena Pelantova et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
The role of food intake regulating peptides in cardiovascular regulation
B. Mikulášková et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Effect of palmitoylated prolactin-relea sing peptide on food intake and neural activation after different routes of peripheral administration in rats
Barbora Mikulaskova et al.
PEPTIDES (2016)
Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice
Zdenko Pirnik et al.
BRAIN RESEARCH (2015)
New insights in leptin resistance mechanisms in mice
Eglantine Balland et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2015)
Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration
L. Maletinska et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Pharmacotherapy for the management of obesity
Dhiren Patel
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats
Jolanta Skarbaliene et al.
PEPTIDES (2015)
Horizons in the Pharmacotherapy of Obesity
Jonathan R. S. Arch
CURRENT OBESITY REPORTS (2015)
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats
Kim V. Andreassen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Investigation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of a Long-Acting a-MSH Analog in Healthy Overweight and Obese Subjects
Jane E. Royalty et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Models and Strategies in the Development of Antiobesity Drugs
A. Agahi et al.
VETERINARY PATHOLOGY (2014)
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Bingxuan Wang et al.
CURRENT DIABETES REVIEWS (2014)
Murine models for pharmacological studies of the metabolic syndrome
Lyne Fellmann et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Anti-obesity drugs: past, present and future
R. John Rodgers et al.
DISEASE MODELS & MECHANISMS (2012)
Administration of an acylated GLP-I and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity
Victor A. Gault et al.
CLINICAL SCIENCE (2011)
Peptides: Important tools for the treatment of central nervous system disorders
Luciana Malavolta et al.
NEUROPEPTIDES (2011)
Biological properties of prolactin-releasing peptide analogs with a modified aromatic ring of a C-terminal phenylalanine amide
Lenka Maletinska et al.
PEPTIDES (2011)
Characterization of prolactin-releasing peptide: Binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor
Jana Maixnerova et al.
PEPTIDES (2011)
Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview
O. Varga et al.
OBESITY REVIEWS (2010)
Endogenous prolactin-releasing peptide regulates food intake in rodents (vol 119, pg 422, 2009)
Yuki Takayanagi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Metabolic dysregulation in the SHROB rat reflects abnonnal expression of transcription factors and enzymes that regulate carbohydrate metabolism
Chuan Xu et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Endogenous prolactin-releasing peptide regulates food intake in rodents
Yuki Takayanagi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Comparison of the Obesity Phenotypes Related to Monosodium Glutamate Effect on Arcuate Nucleus and/or the High Fat Diet Feeding in C57BL/6 and NMRI Mice
R. Matyskova et al.
PHYSIOLOGICAL RESEARCH (2008)
GPR10 deficiency in mice results in altered energy expenditure and obesity
Mikael Bjursell et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
High-fat diets: Modeling the metabolic disorders of human obesity in rodents
Roland Buettner et al.
OBESITY (2007)
Prolactin-releasing peptide mediates cholecystokinin-induced satiety in mice
David A. Bechtold et al.
ENDOCRINOLOGY (2006)
Effect of cholecystokinin on feeding is attenuated in monosodium glutamate obese mice
Lenka Maletinska et al.
REGULATORY PEPTIDES (2006)
Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c
Sudha B. Biddinger et al.
DIABETES (2006)
Why visceral fat is bad: Mechanisms of the metabolic syndrome
Richard N. Bergman et al.
OBESITY (2006)
Different forms of obesity as a function of diet composition
JT Dourmashkin et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus
CT De Souza et al.
ENDOCRINOLOGY (2005)
The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin
S Havelund et al.
PHARMACEUTICAL RESEARCH (2004)
Repeated administration of the anorectic factor prolactin-releasing peptide leads to tolerance to its effects on energy homeostasis
KLJ Ellacott et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors
M Engström et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The prolactin releasing peptides: RF-amide peptides
MM Taylor et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Molecular neurobiology of addiction
EJ Nestler
AMERICAN JOURNAL ON ADDICTIONS (2001)
Alternative role for prolactin-releasing peptide in the regulation of food intake
CB Lawrence et al.
NATURE NEUROSCIENCE (2000)
Prolactin-releasing peptides do not stimulate prolactin release in vivo
H Jarry et al.
NEUROENDOCRINOLOGY (2000)
分享论文
